Morena Pinheiro

    Research Group: 
    Biomedical Genomics
    Unit: 
    CANCER SCIENCE
    Position: 
    Research Assistant
    Office: 
    CL01C71
    Telephone: 
    +34 93 40 39912
    Email: 
    morena.pinheiro@irbbarcelona.org

     

    View research group

    Selected group publications

    The evolution of relapse of adult T cell acute lymphoblastic leukemia
    Inés Sentís, Santiago Gonzalez, Eulalia Genescà, Violeta García-Hernández, Ferran Muiños, Celia Gonzalez, Erika López-Arribillaga, Jessica Gonzalez, Lierni Fernandez-Ibarrondo, Loris Mularoni, Lluís Espinosa, Beatriz Bellosillo, Josep-Maria Ribera, Anna Bigas, Abel Gonzalez-Perez, Nuria Lopez-Bigas
    Genome Biol, (2020)
    A compendium of mutational cancer driver genes
    Francisco Martínez-Jiménez, Ferran Muiños, Inés Sentís, Jordi Deu-Pons, Iker Reyes-Salazar, Claudia Arnedo-Pac, Loris Mularoni, Oriol Pich, Jose Bonet, Hanna Kranas, Abel Gonzalez-Perez, Nuria Lopez-Bigas
    Nat Rev Cancer, (2020)
    Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer
    Francisco Martínez-Jiménez, Ferran Muiños, Erika López-Arribillaga, Nuria Lopez-Bigas & Abel Gonzalez-Perez
    Nat Cancer, (2019)
    The mutational footprints of cancer therapies
    Pich O, Muiños F, Lolkema MP, Steeghs N, Gonzalez-Perez A and Lopez-Bigas N.
    Nat Genet, 51 (12), 1732-1740 (2019)
    Somatic and Germline Mutation Periodicity Follow the Orientation of the DNA Minor Groove around Nucleosomes
    Pich O, Muiños F, Sabarinathan R, Reyes-Salazar I, Gonzalez-Perez A and Lopez-Bigas N.
    Cell, 175 (4), 1074-1087. (2018)
    Reduced mutation rate in exons due to differential mismatch repair
    Frigola J, Sabarinathan R, Mularoni L, Muiños F, Gonzalez-Perez A and López-Bigas N.
    Nat Genet, (2017)
    Nucleotide excision repair is impaired by binding of transcription factors to DNA
    Radhakrishnan Sabarinathan, Loris Mularoni, Jordi Deu-Pons, Abel Gonzalez-Perez, Nuria Lopez-Bigas
    Nature, (2016)
    In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals unexploited targeting opportunities
    Carlota Rubio-Perez#, David Tamborero#, Michael P. Schroeder, Albert A. Antolin, Jordi Deu-Pons, Christian Perez-Llamas, Jordi Mestres, Abel Gonzalez-Perez#, Nuria Lopez-Bigas#
    Cancer Cell, (2015)
    IntOGen-mutations identifies cancer drivers across tumor types
    Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Tamborero D, Schroeder MP, Jene-Sanz A, Santos A & Lopez-Bigas N
    Nature Methods , (2013)
    Full publication list